Modern Diagnostic & Research Centre Limited has announced that its board meeting is scheduled to be held on Friday, May 29, 2026. The meeting has been convened in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Agenda for the Meeting

The board will consider and approve several key financial documents. The primary agenda includes the Quarterly and Annual Financial Statements for the quarter and year ended March 31, 2026. This encompasses the review of the company's performance for Q4FY26 and the full fiscal year FY26.

Additionally, the directors will take on record the Auditors' Report submitted by the Statutory Auditors regarding the Financial Statements and Results for the financial year ended March 31, 2026. The board may also transact any other business that may be placed before it with the permission of the Chairman.

Trading Window Closure

In compliance with the Company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the company's securities remains closed. This restriction applies to Promoters, the Promoter group, Directors, Key Managerial Personnel (KMPs), Connected Persons, and Designated Persons.

The trading window closed effective from April 1, 2026, and will remain shut until 48 hours after the declaration of the Financial Statements and Results for the quarter and year ended March 31, 2026.

Modern Diagnostic & Research Centre Limited has submitted its yearly disclosure to BSE Limited under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. The filing, dated April 5, 2026, details the shareholding status of the company's promoters for the financial year ended March 31, 2026.

Promoter Shareholding Details

The disclosure confirms that the members of the promoter and promoter group, including persons acting in concert, collectively hold 1,09,99,978 equity shares. This stake represents 72.85% of the total shareholding of Modern Diagnostic & Research Centre Limited .

Encumbrance Status

In the declaration submitted to the stock exchange, the promoters explicitly stated that they have not created any encumbrance on these shares during the financial year ended March 31, 2026. This confirmation covers both direct and indirect holdings of the promoter group.

The disclosure was signed by Devender Singh Yadav, Promoter & Managing Director, and Priyanshu Yadav, Company Secretary & Compliance Officer. The document has been submitted for the record of BSE Limited.